University of Minnesota Health has opened the only multidisciplinary services area in the Midwest dedicated to the treatment of conditions affecting the airway. The multidisciplinary team includes surgeons, pulmonologists, and otolaryngologists and provides expertise in minimally invasive endobronchial procedures used to diagnose, biopsy, treat, and palliate complex conditions affecting trachea and bronchi. Some of the conditions treated include tracheal and bronchial stenosis, tracheobronchomalacia, benign and malignant airway obstruction, benign and malignant pleural effusions, severe asthma not responding to medical management, and endobronchial treatment for lung volume reduction surgery. The team also conducts advanced research on airway pathology.
University of Minnesota Health surgeon Eitan Podgaetz, MD, and colleagues have published the first report of an initial presentation of myeloid sarcoma as severe acute tracheal stenosis. Extramedullary involvement of acute myelogenous leukemia (myeloid sarcoma) is rare, as it appears most commonly in soft tissue and lymph nodes. There are very few reports of myeloid sarcoma in the pulmonary system. The patient described in the case study had undergone a failed tracheal dilatation followed by tracheostomy and tissue biopsy. Histology of the tracheal biopsy and bone marrow revealed acute myelogenous leukemia. The authors recommend that myeloid sarcoma become part of the differential diagnosis for acute tracheal stenosis. The case study appears in the March 2015 issue of The Clinical Respiratory Journal.
Used extensively in the diagnosis and treatment of lung cancer, cryotechnology is finding medical applications in a variety of pulmonary diseases, a new report indicates. Cryoprobe transbronchial lung biopsy is being investigated for its potential to improve the diagnostic yield of transbronchial biopsies in parenchymal lung diseases. Surgeons are also using cryoprobes to extract foreign bodies from airways. University of Minnesota Health thoracic surgeons Eitan Podgaetz, MD, and Rafael Andrade, MD, served as contributing authors to the article, which appeared in the January 2015 issue of the Journal of Bronchology & Interventional Pulmonology.
For those with gastroesophageal reflux disease that failed to respond to medication, a new implantable device shows promise in relieving symptoms and limiting side effects.Continue reading
A 36-year-old patient with worsening symptoms of GERD undergoes implantation with a sphincter augmentation device. One week postprocedure, the patient’s symptoms resolved, and he returned to normal diet and activity levels.Continue reading